The Antidepressant Debate: Emerging Research Challenges Decades of Psychiatric Orthodoxy on July 29, 2026 Posted by
Chronic Cough “Comes of Age”: A Landmark Shift in Respiratory Medicine at the Inaugural ERS Cough Conference on July 29, 2026 Posted by
The Sentinel’s Role: Navigating Bipolar Disorder Through the Lens of Friendship and Early Intervention on July 29, 2026 Posted by
Boston Scientific Faces Strategic Reset: Sales Guidance Slashed Amid Market Headwinds on July 29, 2026 Posted by
The Antidepressant Debate: Emerging Research Challenges Decades of Psychiatric Orthodoxy on July 29, 2026 Posted by
Chronic Cough “Comes of Age”: A Landmark Shift in Respiratory Medicine at the Inaugural ERS Cough Conference on July 29, 2026 Posted by
The Sentinel’s Role: Navigating Bipolar Disorder Through the Lens of Friendship and Early Intervention on July 29, 2026 Posted by
Posted in Medical Innovations New Hope for Advanced Lung Cancer: FDA Approves Zidesamtinib for Pre-Treated ROS1-Positive NSCLC on July 23, 2026
Posted in Respiratory Health Precision Oncology Milestone: GSK’s Jideytro (Zidesamtinib) Receives Landmark FDA Approval for ROS1-Positive NSCLC on July 22, 2026
Posted in Medical Innovations A New Horizon in Oncology: Bispecific Antibody Ivonescimab Sets a Higher Bar for Squamous NSCLC Treatment on June 1, 2026 rifanmuazin
Posted in Medical Innovations A New Era in Lung Cancer Care: Selpercatinib Establishes Standard for RET Fusion-Positive NSCLC on May 31, 2026 rifanmuazin
Posted in Medical Innovations A New Frontier in Lung Cancer: Sunvozertinib Challenges Chemotherapy in First-Line NSCLC Treatment on May 30, 2026 rifanmuazin
